Tumor Related Epilepsy
NCT02639325 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-22
Summary
Background:
Some people with brain tumors have seizures related to the tumor. This is called tumor-related epilepsy. Usually brain tumors are treated by removing as much of the brain tumor as possible without causing problems. Researchers think this may improve the outcome for people with brain tumors. It may completely relieve or greatly reduce the number of seizures they have.
Objectives:
To evaluate people with brain tumors that are associated with seizures and to offer surgical treatment. Also, to study how surgery affects seizures.
Eligibility:
People age 8 and older who have a brain tumor with associated seizures. They must be willing to have brain surgery to treat their epilepsy.
Design:
Participants will be screened with a review of their medical records.
Participants will have a medical history and physical exam.
Participants will be admitted to the hospital at NIH. They will have
Medical history
Physical exam
Neurological exam
Tests of memory, attention, and thinking
Questions about their symptoms and quality of life
Blood drawn
They may also have:
MRI or CT scan. They will lie on a table that slides in and out of a machine that takes pictures. For part of the MRI, they will get a dye through an intravenous (IV) catheter.
Video electroencephalography monitoring. Electrodes will be placed on the scalp. The participant s brain waves will be recorded while doing normal activities. Participants will be videotaped.
Participants will keep a seizure diary before and after surgery.
Participants will have surgery to remove their brain tumor and the brain area where their seizures start.
They will stay in the hospital up to a week after surgery.
Participants have for follow-up visits at NIH.
...
Conditions
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Principal Investigators
-
Kareem A Zaghloul, M.D. · National Institute of Neurological Disorders and Stroke (NINDS)
Eligibility
- Min Age
- 8 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-26
- Primary Completion
- 2032-07-01
- Completion
- 2032-07-01
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
NCT00236704 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
NCT00236418 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236691 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
BOTOX Effects on Seizure Severity and Susceptibility
NCT05605756 ·Status: TERMINATED ·Phase: PHASE4
-
Stress and Seizures - Can a Brief Self-help Book Help?
NCT02465047 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
NCT00230698 ·Status: COMPLETED ·Phase: PHASE3
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Preventing Epilepsy After Traumatic Brain Injury With Topiramate
NCT00598923 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2
-
Early Surgical Intervention to Treat Epilepsy
NCT00040326 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
NCT00266591 ·Status: COMPLETED ·Phase: PHASE3
-
Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
NCT03166215 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.
NCT00236847 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy
NCT00297323 ·Status: COMPLETED
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED
-
Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
NCT01390909 ·Status: COMPLETED
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
NCT00266604 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
NCT00236756 ·Status: COMPLETED ·Phase: PHASE3
-
Radiosurgery or Open Surgery for Epilepsy Trial
NCT00860145 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy
NCT00236743 ·Status: COMPLETED ·Phase: PHASE3
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA